Allianz Asset Management Gmb H Bicycle Therapeutics PLC Transaction History
Allianz Asset Management Gmb H
- $72.3 Billion
- Q4 2024
A detailed history of Allianz Asset Management Gmb H transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 24,600 shares of BCYC stock, worth $173,922. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,600
Previous 24,600
-0.0%
Holding current value
$173,922
Previous $557,000
38.24%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BCYC
# of Institutions
103Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$77 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$32.2 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$24.4 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$18.5 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$15.5 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $210M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...